Benjamin A. Belinka
Vorstandsvorsitzender bei Actinobac Biomed, Inc.
Profil
Benjamin A.
Belinka is the founder of Ben Belinka LLC, Durin Technologies, Inc. He is currently the President & Chief Executive Officer at Actinobac Biomed, Inc. Previously, he worked as the Assistant Director-Research & Chemistry at Jazz Pharmaceuticals (EUSA Pharma USA), Inc., as a Principal at Virium Pharmaceuticals, Inc., as a Principal at Sandoz Pharmaceuticals Corp., and as a Vice President at Vectramed, Inc. He holds a doctorate degree from The State University of New York.
Aktive Positionen von Benjamin A. Belinka
| Unternehmen | Position | Beginn |
|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Vorstandsvorsitzender | 17.07.2009 |
| Ben Belinka LLC | Gründer | 27.04.2010 |
Ehemalige bekannte Positionen von Benjamin A. Belinka
| Unternehmen | Position | Ende |
|---|---|---|
Durin Technologies, Inc.
 Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Vorstandsvorsitzender | - |
Virium Pharmaceuticals, Inc.
 Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Corporate Officer/Principal | - |
| Vectramed, Inc. | Corporate Officer/Principal | - |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | - |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
 Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 20.07.2009 |
Ausbildung von Benjamin A. Belinka
| The State University of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Health Technology |
Virium Pharmaceuticals, Inc.
Virium Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Virium Pharmaceuticals, Inc. develops and commercializes novel therapeutics. The company was founded by James M. Pachence and is headquartered in Princeton, NJ. | Health Technology |
| Sandoz Pharmaceuticals Corp. | |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
| Vectramed, Inc. | |
| Ben Belinka LLC | |
Durin Technologies, Inc.
Durin Technologies, Inc. Medical/Nursing ServicesHealth Services Durin Technologies, Inc. engages in the development of blood tests to diagnose and monitor the progress of neurodegenerative diseases. The company was founded Robert G. Nagele in 2010 and is headquartered in Mullica Hill, NJ. | Health Services |
